Efficacy of Fetal Ear Length as a Prenatal Marker of Chromosomal Anomalies: A Prospective, Multicenter Cohort Study in a Southern European Population.


Por: Baldrich E, Comas M, Maldonado A, Blasco M, Manresa-Domínguez JM, Iniguez-Cruz M and Borrell A

Publicada: 1 ene 2026 Ahead of Print: 14 ago 2025
Resumen:
OBJECTIVE: To develop a nomogram of fetal ear length (FEL) by gestational age in a healthy pregnant Southern European population and assess its potential as a prenatal ultrasound marker of chromosomal anomalies in this demographic. METHODS: This prospective, multicenter cohort study included low-risk pregnancies from 11 + 2 to 34 + 6 gestational age. A nomogram was constructed based on gestational age for healthy fetuses with normal perinatal outcomes. Intraobserver and interobserver reliability were evaluated. To assess the efficacy of FEL as a marker of chromosomal anomalies, a multivariate logistic regression analysis was performed; sensitivity and specificity were calculated. RESULTS: A total of 1923 FEL measurements were obtained from 1331 singleton pregnancies. Using data from healthy fetuses, a nomogram was constructed through linear regression analysis. Measurement feasibility was excellent, with intra- and interobserver correlation coefficients of 0.996 (95% confidence interval [CI]: 0.995-0.997) and 0.998 (95% CI: 0.978-0.999), respectively. FEL achieved a sensitivity of 81.8% and a specificity of 49.8% in detecting chromosomal anomalies. Multivariate logistic regression indicated that FEL = 5th percentile significantly increased the likelihood of detecting chromosomal anomalies (odds ratio = 3.11); although the wide 95% CI (1.92-10.7) suggests a cautious interpretation of this finding. CONCLUSIONS: While FEL demonstrates potential as a prenatal marker of chromosomal anomalies, its clinical utility remains limited due to moderate sensitivity and specificity. Further studies are warranted to refine its diagnostic value in routine screening practices.

Filiaciones:
Baldrich E:
 Obstetrics and Gynecology Primary Care Center (ASSIR) Sabadell, Institut Catala de la Salut, Barcelona, Spain

 Research Group on Sexual and Reproductive Healthcare (GRASSIR) (2021-SGR-793), Barcelona, Spain

 Facultat de Medicina i Ciències de la Salut, Universitat de Barcelona (UB), Barcelona, Catalonia, Spain

Comas M:
 Gynecology and Obstetrics Service, Parc Tauli University Hospital, Parc Taulí Research and Innovation Institute (I3PT-CERCA), Universitat Autònoma de Barcelona, Sabadell, Catalonia, Spain

Maldonado A:
 Obstetrics and Gynecology Primary Care Center (ASSIR) Sabadell, Institut Catala de la Salut, Barcelona, Spain

Blasco M:
 Obstetrics and Gynecology Primary Care Center (ASSIR) Sabadell, Institut Catala de la Salut, Barcelona, Spain

:
 Unitat de Suport a la Recerca Metropolitana Nord, Fundació Institut Universitari per a la recerca a l'Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol), Mataró, Catalonia, Spain

Iniguez-Cruz M:
 Unitat de Suport a la Recerca Metropolitana Nord, Fundació Institut Universitari per a la recerca a l'Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol), Mataró, Catalonia, Spain

Borrell A:
 Facultat de Medicina i Ciències de la Salut, Universitat de Barcelona (UB), Barcelona, Catalonia, Spain

 BCNatal Barcelona Centre for Maternal-Fetal and Neonatal Medicine (BCNatal), Hospital Clínic Barcelona, Universitat de Barcelona, Barcelona, Catalonia, Spain
ISSN: 00912751





Journal of Clinical Ultrasound
Editorial
John Wiley & Sons Inc., 111 RIVER ST, HOBOKEN 07030-5774, NJ USA, Estados Unidos America
Tipo de documento: Article
Volumen: 54 Número: 1
Páginas: 88-98
ID de PubMed: 40814105

MÉTRICAS